Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Ophthalmology

Will I Go Completely Blind From Retinitis Pigmentosa?

At a Glance

The vast majority of people with retinitis pigmentosa do not go completely blind. Less than 1% of patients lose all light perception. Most people experience a loss of peripheral vision that leads to legal blindness, but they retain functional central vision well into adulthood.

No, the vast majority of people with retinitis pigmentosa (RP) do not go completely, totally blind. While RP does cause progressive vision loss, losing all ability to perceive light—a condition doctors call no light perception (NLP)—is actually very rare [1]. In fact, research shows that fewer than 1% of patients with RP progress to a state where they have zero light perception [1].

Instead, most people with RP continue to perceive at least light and movement, and many retain a central “island” of vision throughout much of their lives [2][3]. Understanding the difference between legal blindness and total blindness can help ease the fear of living in complete darkness.

Legal Blindness vs. Total Blindness

When doctors talk about blindness in the context of RP, they are almost always referring to legal blindness, not total blindness [4].

Legal blindness is a classification used by governments and agencies to determine eligibility for disability benefits and support services. You can be legally blind and still see remarkably well out of the center of your eye. In the United States, you are considered legally blind if either:

  • Your central visual acuity is 20/200 or worse in your better eye, even with glasses.
  • Your visual field is restricted to 20 degrees or less in diameter [4][5].

Because RP primarily attacks the rod cells (which control peripheral or side vision) before the cone cells (which control central vision), your visual field will usually shrink much faster than your central visual acuity [4]. This means you might develop “tunnel vision” and meet the criteria for legal blindness due to a restricted visual field, even if you can still read a book or see faces clearly straight ahead. One study found that patients with RP reached legal blindness at a median age of 55, most often due to this loss of peripheral vision rather than a loss of central sharpness [5].

Because of this restricted visual field, certain practical daily activities—especially driving—often become unsafe and illegal long before your central vision is impacted. Working with a low-vision specialist or an orientation and mobility instructor can provide you with tools and training to navigate the world safely and maintain your independence.

Keeping Your Central Vision

The progression of RP is typically very slow, giving you and your brain time to adapt to the changes. Your central vision—the sharp, detailed sight you use to read, recognize faces, and watch television—is often preserved into late adulthood [6]. Many people with typical, slowly progressing forms of RP retain useful central vision (such as 20/40 acuity) well into their 40s, 50s, or beyond [2].

Even when the visual field is severely restricted to a small central island, that remaining vision is highly valuable and functional [3]. The exact timeline varies from person to person depending on the specific genetic mutation causing their RP [7]. Knowing your specific mutation through genetic testing can help your doctor give you a more accurate prognosis and inform you about potential gene-specific treatments or clinical trials.

Protecting the Vision You Have

While the genetic progression of RP cannot currently be stopped, you can protect your remaining central vision by monitoring for treatable complications. For example, some people with RP develop cataracts or cystoid macular edema (CME), which is a swelling in the center of the retina that can blur central vision [8][9]. Unlike the genetic vision loss of RP, CME and cataracts are treatable [8].

Regular visits to your eye care team (typically annually, or as recommended by your specialist) will ensure that these secondary issues are caught and managed early, helping you hold onto your central vision for as long as possible.

Common questions in this guide

Does retinitis pigmentosa cause complete blindness?
No, it is very rare for retinitis pigmentosa to cause total, complete blindness. Research shows that fewer than 1% of patients lose all ability to perceive light. Most people with the condition retain at least some light perception and a central island of vision.
What is the difference between legal blindness and total blindness in RP?
In the context of RP, legal blindness usually happens because your peripheral visual field shrinks to 20 degrees or less, creating tunnel vision. You can be classified as legally blind while still having sharp, functional central vision, whereas total blindness means you cannot see anything, including light.
Will I be able to keep my central vision?
Yes, because RP primarily attacks the rod cells responsible for peripheral vision first, your central vision is typically spared for much longer. Many people with slowly progressing forms of RP retain useful central vision well into their 40s, 50s, or beyond.
Is there anything I can do to protect my remaining vision?
While the underlying genetic progression of RP cannot be stopped, you can protect your central vision by treating secondary complications. Conditions like cataracts or cystoid macular edema (CME) can blur your central vision but are treatable by your eye care team.
Why is genetic testing recommended for retinitis pigmentosa?
Identifying your specific genetic mutation gives your eye doctor a better understanding of how fast your condition might progress. It also helps determine if you might be a candidate for emerging gene-specific therapies or clinical trials.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my current visual field measurement in degrees, and how close is that to the threshold for legal blindness?
  2. 2.Do you recommend I undergo genetic testing to identify my specific mutation, and how might that clarify my timeline?
  3. 3.Do you see any signs of treatable complications, such as cystoid macular edema (CME) or cataracts, that could be threatening my central vision?
  4. 4.How frequently should we measure my visual field and central acuity to accurately track my progression (e.g., every 6 months, annually)?
  5. 5.Can you refer me to an orientation and mobility instructor or a low-vision specialist to help me navigate safely as my peripheral vision changes?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    VISUAL IMPAIRMENT IN RETINITIS PIGMENTOSA.

    Vezinaw CM, Fishman GA, McAnany JJ

    Retina (Philadelphia, Pa.) 2020; (40(8)):1630-1633 doi:10.1097/IAE.0000000000002649.

    PMID: 31568063
  2. 2

    Ciliopathy: Usher Syndrome.

    Tsang SH, Aycinena ARP, Sharma T

    Advances in experimental medicine and biology 2018; (1085()):167-170 doi:10.1007/978-3-319-95046-4_32.

    PMID: 30578505
  3. 3

    New COL6A6 Variant Causes Autosomal Dominant Retinitis Pigmentosa in a Four-Generation Family.

    Vaclavik V, Tiab L, Sun YJ, et al.

    Investigative ophthalmology & visual science 2022; (63(3)):23 doi:10.1167/iovs.63.3.23.

    PMID: 35333290
  4. 4

    Disease progression of retinitis pigmentosa caused by PRPF31 variants in a Nordic population: a retrospective study with up to 36 years follow-up.

    Lisbjerg K, Bertelsen M, Lyng Forman J, et al.

    Ophthalmic genetics 2023; (44(2)):139-146 doi:10.1080/13816810.2022.2123006.

    PMID: 36164253
  5. 5

    Visual Field Progression in Retinitis Pigmentosa.

    Xu M, Zhai Y, MacDonald IM

    Investigative ophthalmology & visual science 2020; (61(6)):56 doi:10.1167/iovs.61.6.56.

    PMID: 32589198
  6. 6

    Clinical Characterization of CNGB1-Related Autosomal Recessive Retinitis Pigmentosa.

    Hull S, Attanasio M, Arno G, et al.

    JAMA ophthalmology 2017; (135(2)):137-144 doi:10.1001/jamaophthalmol.2016.5213.

    PMID: 28056120
  7. 7

    PHENOTYPIC CHARACTERISTICS OF ROD-CONE DYSTROPHY ASSOCIATED WITH MYO7A MUTATIONS IN A LARGE FRENCH COHORT.

    Khateb S, Mohand-Saïd S, Nassisi M, et al.

    Retina (Philadelphia, Pa.) 2020; (40(8)):1603-1615 doi:10.1097/IAE.0000000000002636.

    PMID: 31479088
  8. 8

    Macular Alterations in a Cohort of Caucasian Patients Affected by Retinitis Pigmentosa.

    Nebbioso M, Mastrogiuseppe E, Gnolfo E, et al.

    Diagnostics (Basel, Switzerland) 2024; (14(21)) doi:10.3390/diagnostics14212409.

    PMID: 39518376
  9. 9

    Prediction of Visual Acuity After Cataract Surgery Using Optical Coherence Tomography Findings in Eyes With Retinitis Pigmentosa.

    Mao J, Fang D, Chen Y, et al.

    Ophthalmic surgery, lasers & imaging retina 2018; (49(8)):587-594 doi:10.3928/23258160-20180803-06.

    PMID: 30114303

This page answers common questions about vision loss in retinitis pigmentosa for educational purposes only. Always consult your ophthalmologist or a low-vision specialist for advice about your specific prognosis and eye health.

Get notified when new evidence is published on Retinitis pigmentosa.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.